terlipressin has been researched along with Cruveilhier-Baumgarten Syndrome in 82 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (7.32) | 18.7374 |
1990's | 24 (29.27) | 18.2507 |
2000's | 30 (36.59) | 29.6817 |
2010's | 18 (21.95) | 24.3611 |
2020's | 4 (4.88) | 2.80 |
Authors | Studies |
---|---|
Bunchorntavakul, C; Reddy, KR | 1 |
Mohanty, A | 1 |
Barnes, A; Cock, C | 1 |
Gadano, A; Mauro, E | 1 |
Cai, JB; Fan, J; Huang, C; Li, XL; Liu, XF; Shen, YH; Shi, GM; Sun, HC; Xiao, N; Xu, B; Zhou, J; Zhu, XD | 1 |
Baiges, A; Berbel, C; García-Pagán, JC; Hernández-Gea, V | 1 |
Angeli, P; Piano, S; Tonon, M | 1 |
Gupta, M; Khanna, A; Parmar, K; Rathi, S; Singh, A; Singh, SK; Singh, V | 1 |
Dayal, VM; Jha, A; Jha, SK; Mishra, M | 1 |
Ding, C; Fan, X; He, C; Li, J; Wu, X | 1 |
Ahmed, F; Ali, L; Haider, S; Hussain, Q; Liaquat, H; Shahbaz, S; Solangi, NM | 1 |
Blokhina, NV; Pasechnik, IN | 1 |
Huang, HC; Lee, FY; Lee, SD; Lin, HC; Tsai, MH; Wang, SS | 1 |
Berzigotti, A; Bosch, J | 1 |
Bertino, G; Crisafulli, E; Demma, S; Koukias, N; Privitera, G; Purrello, F; Spadaro, L; Tsochatzis, EA | 1 |
Kim, SM; Song, IH | 1 |
Lebrec, D; Moreau, R | 1 |
Atsukawa, M; Fukuda, T; Harimoto, H; Kanazawa, H; Katakura, T; Kidokoro, H; Kimura, Y; Matsushita, Y; Nakatsuka, K; Narahara, Y; Sakamoto, C; Taki, Y | 1 |
Schepke, M | 1 |
Angus, PW; Testro, AG | 1 |
Bouix, J | 1 |
Baltayiannis, G; Fotopoulos, A; Kalambokis, G; Pakou, B; Tsianos, EV; Tsiouris, S | 1 |
Arroyo, V; Bosch, J; Escorsell, A; Fagundes, C; Fernández, J; Ginès, P; González-Abraldes, J; Guevara, M; Lens, S; Martín-Llahí, M; Mas, A; Pavesi, M; Pereira, G; Solà, E | 1 |
Bendtsen, F; Krag, A; Møller, S | 1 |
Farber, E; Gershovich, M; Soboh, S; Yefet, E | 1 |
Alegre, F; Banales, JM; Barbero, R; Carreño, N; Chang, HC; García, M; Herrero, I; Morán, A; Pérez-Vizcaíno, F; Prieto, J; Quiroga, J; Reboredo, M; Rodríguez-Ortigosa, CM; Sangro, B | 1 |
Baik, SK; Choi, YJ; Jeong, PH; Kim, HS; Kim, MY; Kim, ND; Kim, YJ; Kwon, SO; Lee, DK; Park, DH; Park, JW | 1 |
Baik, SK; Choi, YJ; Kim, HS; Kim, MY; Kim, YJ; Kwon, SO; Lee, DK; Park, DH; Park, JW | 1 |
Bendtsen, F; Hansen, EF; Henriksen, JH; Kiszka-Kanowitz, M; Møller, S | 1 |
Chan, CC; Chang, FY; Chen, YC; Hou, MC; Huang, HC; Lee, FY; Lee, SD; Lin, HC; Lu, RH; Wang, SS; Wu, SL | 1 |
Chang, FY; Hou, MC; Huang, YT; Lee, FY; Lee, SD; Lin, HC; Yang, YY | 1 |
Calès, P; Dib, N; Oberti, F | 1 |
Halpern, EJ | 1 |
Baik, SK; Chang, SJ; Han, KH; Kim, HS; Kim, JW; Kim, SH; Kim, YJ; Kwon, SO; Lee, DK; Lee, SS; Park, JW; Um, SH | 1 |
Cazzaniga, M; Gobbo, G; Salerno, F | 1 |
Kalambokis, G; Korantzopoulos, P; Nikas, SA; Theodorou, A; Tsianos, EV | 1 |
de Franchis, R; Dell'Era, A; Iannuzzi, F | 1 |
Kohaus, HM | 1 |
Bretagne, JF; Gosselin, M; Heresbach, D | 1 |
Kitsenko, EA; Peresta, IuIu | 1 |
Groszmann, RJ; Lopez-Talavera, JC | 1 |
Bernard, B; Valla, D | 1 |
Bordas, JM; Bosch, J; Llach, J; Panés, J; Piqué, JM; Rodés, J; Terés, J | 1 |
Cailmail, S; Hadengue, A; Lebrec, D; Moreau, R; Oberti, F; Sogni, P | 1 |
Heinemann, A; Stauber, RE | 1 |
Nevens, F | 1 |
Bandi, JC; Bosch, J; Escorsell, A; Feu, F; García-Pagan, JC; Moitinho, E; Rodés, J | 1 |
Blanc, P; Bories, JM; David, XR; Desprez, D; García-Compeán, D; Larrey, D; Michel, H; Michel, J; Pageaux, GP | 1 |
Burroughs, AK; Patch, D | 1 |
Cailmail, S; Lebrec, D; Moreau, R; Valla, D | 1 |
Renner, EL | 1 |
Bandi, JC; Bernadich, C; Bosch, J; Melin, P | 1 |
Calès, P; Kaassis, M; Oberti, F; Pilette, C; Rifflet, H; Trouvé, R; Veal, N | 1 |
Chan, CC; Chang, FY; Chu, CJ; Hou, MC; Lee, FY; Lee, SD; Lin, HC; Tai, CC; Wang, SS; Wu, SL | 1 |
Bosch, J; Escorsell, A | 1 |
Chern, JW; Hong, CY; Huang, YT; Lin, HC; Lin, LC | 1 |
Chung, SC; Lee, YT; Sung, JJ; Yu, AL; Yung, MY | 1 |
Fernández, J; Hinojosa, J; Llorca, P; Molés, JR; Primo, J | 1 |
Bolondi, L; Donati, G; Gaiani, S; Masi, L; Piscaglia, F | 1 |
Chang, FC; Chen, KJ; Hong, CY; Huang, YT; Lin, HC; Lin, JG | 1 |
Becker, U; Bendtsen, F; Brinch, K; Hansen, EF; Henriksen, JH; Møller, S | 2 |
Bosch, J | 1 |
Chan, CC; Chang, FY; Chu, CJ; Lee, FY; Lee, SD; Lin, HC; Wang, SS; Wu, SL | 1 |
Lebrec, D | 3 |
Jalan, R; Kapoor, D | 1 |
Chan, CC; Chang, FY; Chen, CT; Chu, CJ; Hou, MC; Huang, HC; Lee, FY; Lee, SD; Lin, HC; Wang, SS; Wu, SL | 2 |
Chang, FY; Hou, MC; Lee, FY; Lee, SD; Lee, WC; Lin, HC; Yang, YY | 1 |
Calès, P; Kaassis, M; Moal, F; Oberti, F; Roy, E; Saumet, JL; Trouvé, R; Veal, N; Vuillemin, E; Wang, J | 1 |
Bosch, J; D'Ocon, P; Esplugues, JV; García-Zaragoza, E; Martínez-Cuesta, MA; Melin, P; Noguera, MA; Ramírez, MC | 1 |
Chang, FY; Hou, MC; Huang, YT; Lee, FY; Lee, SD; Lee, WC; Lin, HC; Yang, YY | 1 |
Arroyo, V | 1 |
Gaudin, C; Hadengue, A; Kleber, G; Lebrec, D; Moreau, R; Sogni, P; Soubrane, O | 1 |
Geller, LI | 1 |
Cervinka, J; Jedlicka, J; Kaláb, M; Kordac, V; Marecek, Z; Petrtýl, J; Srnský, J; Vrána, J | 1 |
McLaren, MI; Taylor, I | 1 |
Maier, KP | 1 |
Angeli, P; Battaglia, G; Bolognesi, M; Finucci, G; Gatta, A; Merkel, C; Zuin, R | 1 |
Lindecken, KD; Rey, C; Schäfer, H; Schoenemann, J; Willems, MG | 1 |
27 review(s) available for terlipressin and Cruveilhier-Baumgarten Syndrome
Article | Year |
---|---|
Pharmacologic Management of Portal Hypertension.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Antagonists; Anticoagulants; Antihypertensive Agents; Carvedilol; Esophageal and Gastric Varices; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Hemostasis, Endoscopic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Portal; Nitrates; Octreotide; Propranolol; Somatostatin; Terlipressin; Vasodilator Agents | 2019 |
Peptide-based therapy in portal hypertension.
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hepatorenal Syndrome; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Octreotide; Peptide Fragments; Somatostatin; Terlipressin | 2020 |
What's new in portal hypertension?
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Portasystemic Shunt, Transjugular Intrahepatic; Terlipressin | 2020 |
Acute variceal bleeding: risk stratification and management (including TIPS).
Topics: Acute Disease; Combined Modality Therapy; Endoscopy, Digestive System; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Ligation; Liver Cirrhosis; Lypressin; Portasystemic Shunt, Transjugular Intrahepatic; Risk Assessment; Terlipressin; Vasoconstrictor Agents | 2018 |
Management of ascites and hepatorenal syndrome.
Topics: Acute Kidney Injury; Albumins; Ascites; Bacterial Translocation; Diet, Sodium-Restricted; Diuretics; Hemodynamics; Hepatorenal Syndrome; Humans; Hypertension, Portal; Hyponatremia; Liver Cirrhosis; Liver Transplantation; Lypressin; Paracentesis; Peritonitis; Portasystemic Shunt, Transjugular Intrahepatic; Splanchnic Circulation; Terlipressin; Vasoconstrictor Agents; Vasodilation | 2018 |
[The modern possibilities of the hepato-renal syndrome treatment].
Topics: Comparative Effectiveness Research; Hemodynamics; Hepatorenal Syndrome; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Nitric Oxide; Outcome Assessment, Health Care; Portasystemic Shunt, Transjugular Intrahepatic; Randomized Controlled Trials as Topic; Renal Replacement Therapy; Terlipressin; Vasoconstrictor Agents | 2013 |
Pharmacologic management of portal hypertension.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Antagonists; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antihypertensive Agents; Antioxidants; Carbazoles; Carvedilol; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Portal; Liver Circulation; Lypressin; Portal Pressure; Propanolamines; Renin-Angiotensin System; Somatostatin; Splanchnic Circulation; Terlipressin; Vascular Resistance; Vasodilator Agents | 2014 |
Emerging hepatic syndromes: pathophysiology, diagnosis and treatment.
Topics: Acute Kidney Injury; Adrenal Insufficiency; Ascites; Creatinine; Evidence-Based Medicine; Hepatorenal Syndrome; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Transplantation; Lypressin; Midodrine; Norepinephrine; Octreotide; Plasma Substitutes; Portasystemic Shunt, Transjugular Intrahepatic; Serum Albumin; Terlipressin; Vasodilator Agents; Vasopressins | 2016 |
[Acute Kidney Injury in Cirrhotic Patients with Portal Hypertension].
Topics: Acute Kidney Injury; Biomarkers; Creatinine; Humans; Hypertension, Portal; Kidney Transplantation; Liver Cirrhosis; Lypressin; Serum Albumin; Terlipressin | 2016 |
Acute kidney injury: new concepts. Hepatorenal syndrome: the role of vasopressors.
Topics: Acute Kidney Injury; Antihypertensive Agents; Humans; Hypertension, Portal; Lypressin; Terlipressin; Treatment Outcome; Vasopressins | 2008 |
[Importance of drug treatment to lower portal pressure in the therapy of variceal bleeding].
Topics: Adrenergic beta-Antagonists; Anti-Bacterial Agents; Drug Therapy, Combination; Esophageal and Gastric Varices; Esophagoscopy; Gastrointestinal Hemorrhage; Hormones; Humans; Hypertension, Portal; Infection Control; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Lypressin; Portal Pressure; Secondary Prevention; Somatostatin; Terlipressin; Vasoconstrictor Agents; Vasodilator Agents | 2009 |
Current management of the complications of portal hypertension: variceal bleeding and ascites.
Topics: Algorithms; Anti-Bacterial Agents; Ascites; Collateral Circulation; Diuretics; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hepatorenal Syndrome; Hormones; Hypertension, Portal; Liver Cirrhosis; Lypressin; Peritonitis; Portasystemic Shunt, Transjugular Intrahepatic; Sclerotherapy; Secondary Prevention; Somatostatin; Spironolactone; Terlipressin; Vascular Resistance; Vasoconstrictor Agents; Vasodilation; Vasopressins | 2006 |
Acute variceal bleeding: pharmacological treatment and primary/secondary prophylaxis.
Topics: Acute Disease; Adrenergic beta-Antagonists; Antibiotic Prophylaxis; Drug Therapy, Combination; Esophageal and Gastric Varices; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Octreotide; Somatostatin; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2008 |
[Emergency medical treatment of portal hypertension].
Topics: Combined Modality Therapy; Emergency Medicine; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Octreotide; Sclerotherapy; Somatostatin; Terlipressin | 1995 |
[Drug therapy and prevention of hemorrhage in esophageal and gastric varices].
Topics: Adrenergic beta-Antagonists; Animals; Dogs; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Lypressin; Nitroprusside; Pituitary Hormones, Posterior; Recurrence; Somatostatin; Terlipressin; Vasopressins | 1995 |
[Efficacy and mode of action of vasopressin in the treatment of digestive hemorrhages caused by rupture of esophageal or gastric varices].
Topics: Drug Therapy, Combination; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Hypertension, Portal; Lypressin; Nitro Compounds; Sclerotherapy; Terlipressin; Vasopressins | 1994 |
Pharmacological treatment of portal hypertension.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Catheterization; Clinical Trials as Topic; Diuretics; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Lypressin; Metoclopramide; Molsidomine; Octreotide; Portasystemic Shunt, Surgical; Sclerotherapy; Somatostatin; Terlipressin; Vasodilator Agents; Vasopressins | 1995 |
[Esophageal varices].
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Combined Modality Therapy; Drug Therapy, Combination; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Lypressin; Nitroglycerin; Octreotide; Recurrence; Risk Factors; Terlipressin | 1997 |
[Terlipressin in the treatment of portal hypertension].
Topics: Antihypertensive Agents; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Hypertension, Portal; Lypressin; Terlipressin | 1998 |
Doppler evaluation of the effects of pharmacological treatment of portal hypertension.
Topics: Adrenergic Agents; Adrenergic beta-Antagonists; Antihypertensive Agents; Calcium Channel Blockers; Diuretics; Domperidone; Humans; Hypertension, Portal; Lypressin; Metoclopramide; Nitrates; Octreotide; Portal System; Somatostatin; Terlipressin; Ultrasonography, Doppler; Ultrasonography, Doppler, Duplex; Vasopressins | 1999 |
The sixth Carlos E. Rubio Memorial Lecture. Prevention and treatment of variceal hemorrhage.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Double-Blind Method; Drug Therapy, Combination; Endoscopy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Ligation; Liver Transplantation; Lypressin; Middle Aged; Mineralocorticoid Receptor Antagonists; Nadolol; Nitric Oxide Donors; Nitroglycerin; Portasystemic Shunt, Transjugular Intrahepatic; Propranolol; Randomized Controlled Trials as Topic; Recurrence; Sclerotherapy; Spironolactone; Terlipressin; Vasoconstrictor Agents; Vasodilator Agents | 2000 |
Pretransplantation gastrointestinal bleeding.
Topics: Adrenergic beta-Antagonists; Gastrointestinal Hemorrhage; Hemostasis, Endoscopic; Humans; Hypertension, Portal; Liver Transplantation; Lypressin; Risk Factors; Secondary Prevention; Survival Analysis; Terlipressin; Vasoconstrictor Agents | 2000 |
Drug therapy for portal hypertension.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Gastroscopy; Humans; Hypertension, Portal; Lypressin; Research; Somatostatin; Terlipressin; Vasopressins | 2001 |
[Physiopathology of refractory ascites and the hepatorenal syndrome].
Topics: Ascites; Glomerular Filtration Rate; Hepatorenal Syndrome; Humans; Hypertension, Portal; Hypotension; Kidney; Liver Cirrhosis; Lypressin; Ornipressin; Paracentesis; Peritoneovenous Shunt; Peritonitis; Plasma Substitutes; Renin-Angiotensin System; Splanchnic Circulation; Sympathetic Nervous System; Tachycardia; Terlipressin; Vasoconstriction | 2002 |
[Chemotherapy of portal hypertension].
Topics: Antihypertensive Agents; Drug Evaluation; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Infusions, Intra-Arterial; Lypressin; Mesenteric Arteries; Propranolol; Terlipressin; Vasopressins | 1991 |
Advances in managing variceal bleeding in portal hypertension.
Topics: Catheterization; Embolization, Therapeutic; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Ligation; Lypressin; Portacaval Shunt, Surgical; Portasystemic Shunt, Surgical; Propranolol; Resuscitation; Sclerosing Solutions; Somatostatin; Splenorenal Shunt, Surgical; Terlipressin; Vasopressins | 1986 |
[Drug treatment of bleeding esophageal varices. Acute therapy and prevention of recurrence].
Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Drug Therapy, Combination; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Lypressin; Nitroglycerin; Nitroprusside; Recurrence; Risk; Somatostatin; Terlipressin; Vasopressins | 1986 |
17 trial(s) available for terlipressin and Cruveilhier-Baumgarten Syndrome
Article | Year |
---|---|
A prospective study of the effect of terlipressin on portal vein pressure and clinical outcomes after hepatectomy: A pilot study.
Topics: Blood Pressure; Drainage; Female; Hepatectomy; Humans; Hypertension, Portal; Liver Failure; Male; Middle Aged; Pilot Projects; Portal Vein; Postoperative Complications; Prospective Studies; Terlipressin; Vasoconstrictor Agents | 2020 |
Comparison of continuous versus intermittent infusions of terlipressin for the control of acute variceal bleeding in patients with portal hypertension: An open-label randomized controlled trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Drug Administration Schedule; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Infusions, Intravenous; Injections, Intravenous; Lypressin; Male; Middle Aged; Portal Pressure; Terlipressin; Treatment Outcome; Vasoconstrictor Agents; Young Adult | 2018 |
Hemodynamic effects of continuous versus bolus infusion of terlipressin for portal hypertension: a randomized comparison.
Topics: Adult; Aged; Female; Hemodynamics; Humans; Hypertension, Portal; Infusions, Intravenous; Injections, Intravenous; Lypressin; Male; Middle Aged; Monitoring, Physiologic; Portal Pressure; Portasystemic Shunt, Transjugular Intrahepatic; Terlipressin; Young Adult | 2013 |
Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.
Topics: Aged; Blood Pressure; Cardiac Output; Female; Heart Rate; Hemodynamics; Hepatorenal Syndrome; Humans; Hypertension, Portal; Injections, Intravenous; Liver Circulation; Liver Cirrhosis; Lypressin; Male; Middle Aged; Neurotransmitter Agents; Placebo Effect; Renal Circulation; Terlipressin; Treatment Outcome; Ultrasonography, Doppler; Vascular Resistance; Vasoconstrictor Agents | 2009 |
Effects of terlipressin and somatostatin on liver and thorax blood volumes in patients with cirrhosis.
Topics: Esophageal and Gastric Varices; Female; Gamma Cameras; Hemodynamics; Hormones; Humans; Hypertension, Portal; Infusions, Intravenous; Liver Circulation; Liver Cirrhosis; Lypressin; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Somatostatin; Technetium Tc 99m Sestamibi; Terlipressin; Thorax; Vasoconstrictor Agents | 2010 |
Effect of terlipressin on blood volume distribution in patients with cirrhosis.
Topics: Adult; Blood Volume; Female; Hemodynamics; Humans; Hypertension, Portal; Liver Circulation; Liver Cirrhosis, Alcoholic; Lypressin; Male; Middle Aged; Terlipressin; Vasoconstrictor Agents | 2004 |
Drug therapy for acute bleeding from portal hypertensive gastropathy.
Topics: Acute Disease; Double-Blind Method; Gastric Mucosa; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Perfusion; Stomach Diseases; Terlipressin; Vasoconstrictor Agents; Vasopressins | 1995 |
Reduction of gastric hyperemia by glypressin and vasopressin administration in cirrhotic patients with portal hypertensive gastropathy.
Topics: Double-Blind Method; Female; Gastric Mucosa; Gastrointestinal Hemorrhage; Gastroscopy; Humans; Hyperemia; Hypertension, Portal; Laser-Doppler Flowmetry; Liver Cirrhosis; Lypressin; Male; Middle Aged; Oxygen; Regional Blood Flow; Spectrophotometry; Stomach Diseases; Terlipressin; Vasopressins | 1994 |
Non-invasive variceal pressure measurements: validation and clinical implications.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure Determination; Double-Blind Method; Esophageal and Gastric Varices; Esophagoscopy; Female; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Male; Middle Aged; Propranolol; Reproducibility of Results; Spironolactone; Terlipressin; Venous Pressure | 1996 |
Time profile of the haemodynamic effects of terlipressin in portal hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Dose-Response Relationship, Drug; Double-Blind Method; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Hypertension, Portal; Infusions, Intravenous; Liver Cirrhosis; Lypressin; Male; Middle Aged; Recurrence; Splanchnic Circulation; Terlipressin | 1997 |
Treatment of active gastroesophageal variceal bleeding with terlipressin or hemostatic balloon in patients with cirrhosis. A randomized controlled trial.
Topics: Adult; Aged; Antihypertensive Agents; Catheterization; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hemodynamics; Hemostatic Techniques; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Male; Middle Aged; Recurrence; Survival Rate; Terlipressin; Treatment Outcome | 1997 |
Use of color Doppler EUS in assessing azygos blood flow for patients with portal hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Azygos Vein; Endosonography; Female; Humans; Hypertension, Portal; Lypressin; Male; Middle Aged; Regional Blood Flow; Somatostatin; Statistics, Nonparametric; Terlipressin; Time Factors; Ultrasonography, Doppler, Color | 1999 |
Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients.
Topics: Adult; Aged; Female; Hemodynamics; Humans; Hypertension, Portal; Liver Cirrhosis, Alcoholic; Lypressin; Male; Middle Aged; Terlipressin; Vasoconstrictor Agents | 2000 |
Endoscopic Doppler ultrasound for measurement of azygos blood flow. Validation against thermodilution and assessment of pharmacological effects of terlipressin in portal hypertension.
Topics: Adult; Aged; Azygos Vein; Blood Flow Velocity; Cross-Over Studies; Double-Blind Method; Endosonography; Female; Humans; Hypertension, Portal; Injections, Intravenous; Lypressin; Male; Middle Aged; Probability; Reference Values; Sensitivity and Specificity; Terlipressin; Thermodilution; Ultrasonography, Doppler | 2001 |
Hemodynamic effects of a combination of prazosin and terlipressin in patients with viral cirrhosis.
Topics: Antihypertensive Agents; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Male; Middle Aged; Prazosin; Terlipressin | 2001 |
Hemodynamic effects of a combination of octreotide and terlipressin in patients with viral hepatitis related cirrhosis.
Topics: Aged; Cardiac Output; Drug Therapy, Combination; Female; Hemodynamics; Hepatitis B; Hepatitis C; Humans; Hypertension, Portal; Infusions, Intravenous; Injections, Intravenous; Liver Circulation; Liver Cirrhosis; Lypressin; Male; Middle Aged; Octreotide; Terlipressin; Vascular Resistance; Vasoconstrictor Agents; Venous Pressure | 2002 |
[Hemodynamic effects of the administration of terlipressin alone or combined with nitroglycerin in patients with cirrhosis].
Topics: Blood Pressure; Cardiac Output; Catecholamines; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension, Portal; Infusions, Intravenous; Injections, Intravenous; Liver Cirrhosis, Alcoholic; Lypressin; Male; Middle Aged; Nitroglycerin; Terlipressin | 1992 |
38 other study(ies) available for terlipressin and Cruveilhier-Baumgarten Syndrome
Article | Year |
---|---|
Rapid reversal of hyponatraemia in a patient with non-cirrhotic portal hypertension treated with terlipressin.
Topics: Adult; Anti-Infective Agents, Urinary; Humans; Hypertension, Portal; Hyponatremia; Male; Sodium; Terlipressin; Thrombosis; Vasoconstrictor Agents | 2020 |
Portal Hypertensive Vesiculopathy: A Rare Cause of Hematuria and a Unique Management Strategy.
Topics: Antihypertensive Agents; Blood Transfusion; Embolization, Therapeutic; Enbucrilate; Hematuria; Humans; Hypertension, Portal; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Terlipressin; Tissue Adhesives; Urinary Bladder; Varicose Veins | 2018 |
Estimating effect of terlipressin on portal pressure in cirrhosis by observing hepatic vein Doppler waveform.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure Determination; Female; Hepatic Veins; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Male; Middle Aged; Terlipressin; Ultrasonography, Doppler | 2013 |
Adrenal dysfunction in portal hypertensive rats with acute hemorrhage.
Topics: Adrenal Glands; Animals; Aorta, Abdominal; Body Weight; Corticosterone; Dexamethasone; Gene Expression Regulation, Enzymologic; Hemodynamics; Hemorrhage; Hypertension, Portal; Hypothalamo-Hypophyseal System; Lypressin; Male; Mesenteric Artery, Superior; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Terlipressin; Tumor Necrosis Factor-alpha | 2014 |
Targeting circulatory dysfunction in cirrhosis: terlipressin and the hepatorenal syndrome.
Topics: Hemodynamics; Hepatorenal Syndrome; Humans; Hypertension, Portal; Liver Circulation; Liver Cirrhosis; Lypressin; Renal Circulation; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2009 |
[Management of digestive system hemorrhages].
Topics: Gastrointestinal Agents; Gastrointestinal Hemorrhage; Hematemesis; Humans; Hypertension, Portal; Lypressin; Octreotide; Somatostatin; Terlipressin | 2010 |
Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension.
Topics: Adult; Aged; Bilirubin; Creatinine; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Hyponatremia; International Normalized Ratio; Liver Cirrhosis; Lypressin; Male; Middle Aged; Serum Albumin; Sodium; Terlipressin | 2010 |
Hyponatremia in patients treated with terlipressin: mechanisms and implications for clinical practice.
Topics: Contraindications; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Hyponatremia; Hypotonic Solutions; Lypressin; Receptors, Vasopressin; Sodium; Terlipressin | 2011 |
Extensive epidermal necrosis due to terlipressin.
Topics: Aged; Epidermis; Esophageal and Gastric Varices; Fatal Outcome; Humans; Hypertension, Portal; Ischemia; Lypressin; Male; Necrosis; Skin; Terlipressin; Vasoconstrictor Agents | 2011 |
Zolmitriptan: a novel portal hypotensive agent which synergizes with propranolol in lowering portal pressure.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Body Weight; Carbon Tetrachloride; Catecholamines; Common Bile Duct; Cyclic AMP; Drug Synergism; Drug Therapy, Combination; Hypertension, Portal; Infusions, Intravenous; Ligation; Liver Cirrhosis, Experimental; Lypressin; Mesenteric Artery, Superior; Oxazolidinones; Perfusion; Portal Pressure; Propranolol; Rats; Regional Blood Flow; Renal Artery; Splanchnic Circulation; Sympathectomy; Terlipressin; Tryptamines; Vasodilation | 2013 |
[Comparison of Doppler ultrasonography and hepatic venous pressure gradient in assessing portal hypertension in liver cirrhosis].
Topics: Antihypertensive Agents; Blood Flow Velocity; Female; Hepatic Veins; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Male; Middle Aged; Prospective Studies; Terlipressin; Ultrasonography, Doppler; Venous Pressure | 2002 |
Comparison of Doppler ultrasonography and the hepatic venous pressure gradient in assessing portal hypertension in liver cirrhosis.
Topics: Adult; Aged; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Female; Hepatic Veins; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Male; Middle Aged; Prospective Studies; Pulsatile Flow; Reproducibility of Results; Severity of Illness Index; Terlipressin; Ultrasonography, Doppler; Vascular Resistance | 2003 |
Nitric oxide synthase expression in the splanchnic hyposensitivity to glypressin of a hemorrhage-transfused rat model with portal hypertension.
Topics: Animals; Antihypertensive Agents; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Hemorrhage; Hypertension, Portal; Lypressin; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Terlipressin | 2004 |
Inhibition of glucagon improves splanchnic hyporesponse to terlipressin in cirrhotic rats with blood retention in the gastric lumen.
Topics: Animals; Antibodies; Blood; Drug Synergism; Gastric Lavage; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Glucagon; Hypertension, Portal; Liver Cirrhosis; Lypressin; Male; Octreotide; Rats; Rats, Sprague-Dawley; Splanchnic Circulation; Stomach; Terlipressin; Vasoconstrictor Agents | 2005 |
Science to practice: Noninvasive assessment of portal hypertension--can US aid in the prediction of portal pressure and monitoring of therapy?
Topics: Antihypertensive Agents; Humans; Hypertension, Portal; Lypressin; Monitoring, Physiologic; Portal Pressure; Prognosis; Terlipressin; Ultrasonography, Doppler | 2006 |
Recent variceal bleeding: Doppler US hepatic vein waveform in assessment of severity of portal hypertension and vasoactive drug response.
Topics: Antihypertensive Agents; Esophageal and Gastric Varices; Female; Hepatic Veins; Humans; Hypertension, Portal; Liver Cirrhosis; Logistic Models; Lypressin; Male; Middle Aged; Monitoring, Physiologic; Portal Pressure; Prognosis; Prospective Studies; Sensitivity and Specificity; Terlipressin; Ultrasonography, Doppler | 2006 |
Pharmacological treatment of hepatorenal syndrome: a note of optimism.
Topics: Albumins; Baroreflex; Blood Pressure; Central Venous Pressure; Clinical Trials as Topic; Dose-Response Relationship, Drug; Hepatorenal Syndrome; Humans; Hypertension, Portal; Hypovolemia; Kidney; Lypressin; Norepinephrine; Portacaval Shunt, Surgical; Regional Blood Flow; Renal Artery; Terlipressin; Treatment Outcome; Vasoconstriction; Vasoconstrictor Agents | 2007 |
Significant improvement of portopulmonary hypertension after 1-week terlipressin treatment.
Topics: Adult; Antihypertensive Agents; Follow-Up Studies; Humans; Hypertension, Portal; Hypertension, Pulmonary; Injections, Intravenous; Lypressin; Male; Shock, Septic; Terlipressin; Time Factors | 2008 |
[Therapy of acute esophageal varices hemorrhage. Animal-experiment and clinical results].
Topics: Acute Disease; Animals; Dogs; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Hypertension, Portal; Liver Circulation; Lypressin; Oxygen; Sclerosing Solutions; Terlipressin | 1983 |
Effects of terlipressin on hemodynamics and oxygen content in conscious portal vein stenosed and cirrhotic rats receiving propranolol.
Topics: Animals; Blood Pressure; Carbon Dioxide; Heart Rate; Hemodynamics; Hydrogen-Ion Concentration; Hypertension, Portal; Liver Circulation; Liver Cirrhosis, Experimental; Lypressin; Male; Oxygen; Oxygen Consumption; Partial Pressure; Portal System; Portal Vein; Propranolol; Rats; Rats, Sprague-Dawley; Splanchnic Circulation; Terlipressin; Vascular Resistance | 1993 |
Effect of terlipressin on in vitro vascular hyporeactivity of portal hypertensive rats.
Topics: Acetylcholine; Adrenergic alpha-Agonists; Animals; Antihypertensive Agents; Disease Models, Animal; Enzyme Inhibitors; Hypertension, Portal; In Vitro Techniques; Lypressin; Male; Mesenteric Arteries; Methoxamine; NG-Nitroarginine Methyl Ester; Perfusion; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Terlipressin; Vasodilation | 1996 |
Haemodynamic responses to a combination of terlipressin and octreotide in portal hypertensive rats.
Topics: Animals; Antihypertensive Agents; Drug Interactions; Drug Therapy, Combination; Hemodynamics; Hormones; Hypertension, Portal; Lypressin; Male; Octreotide; Rats; Rats, Sprague-Dawley; Splanchnic Circulation; Terlipressin | 1997 |
Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Diuresis; Dose-Response Relationship, Drug; Female; Hemodynamics; Hypertension, Portal; Lypressin; Male; Mesenteric Artery, Superior; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Splanchnic Circulation; Terlipressin; Time Factors; Vasoconstrictor Agents; Vasopressins | 1998 |
Hemodynamic effects of terlipressin and octreotide administration alone or in combination in portal hypertensive rats.
Topics: Animals; Antihypertensive Agents; Drug Therapy, Combination; Hemodynamics; Hypertension, Portal; Lypressin; Male; Octreotide; Rats; Rats, Sprague-Dawley; Splanchnic Circulation; Terlipressin | 1998 |
Aminoguanidine ameliorates splanchnic hyposensitivity to glypressin in a haemorrhage-transfused rat model of portal hypertension.
Topics: Animals; Drug Therapy, Combination; Guanidines; Hemodynamics; Hemorrhage; Hypertension, Portal; Lypressin; Male; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Splanchnic Circulation; Terlipressin; Vasoconstrictor Agents | 1998 |
Portal hypotensive effects of combined terlipressin and DL-028, a synthetic alpha 1 adrenoceptor antagonist administration on anesthetized portal hypertensive rats.
Topics: Adrenergic alpha-Antagonists; Anesthesia; Animals; Antihypertensive Agents; Disease Models, Animal; Drug Therapy, Combination; Hypertension, Portal; Lypressin; Male; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Terlipressin; Venous Pressure | 1999 |
[Terlipressin in the treatment of portal hypertension].
Topics: Antihypertensive Agents; Humans; Hypertension, Portal; Lypressin; Meta-Analysis as Topic; Terlipressin | 1999 |
Beneficial effects of combined terlipressin and tetramethylpyrazine administration on portal hypertensive rats.
Topics: Animals; Antihypertensive Agents; Cholestasis; Disease Models, Animal; Drug Therapy, Combination; Hemodynamics; Hypertension, Portal; Lypressin; Male; Portal Vein; Pyrazines; Rats; Rats, Sprague-Dawley; Terlipressin; Vasodilator Agents | 1999 |
Effects of prostacyclin inhibition on splanchnic hyposensitivity to glypressin in a hemorrhage-transfused rat model of portal hypertension.
Topics: Analysis of Variance; Animals; Antihypertensive Agents; Blood Transfusion; Cyclooxygenase Inhibitors; Gastrointestinal Hemorrhage; Hemodynamics; Hypertension, Portal; Indomethacin; Lypressin; Male; Rats; Rats, Sprague-Dawley; Splanchnic Circulation; Terlipressin | 2000 |
Vascular hyporesponsiveness in cirrhosis - many facets of a common problem!
Topics: Animals; Biomechanical Phenomena; Epoprostenol; Hypertension, Portal; Liver Cirrhosis; Lypressin; Models, Biological; Rats; Terlipressin | 2001 |
Inhibition of prostacyclin by indomethacin ameliorates the splanchnic hyposensitivity to glypressin in haemorrhage-transfused common bile duct-ligated rats.
Topics: Animals; Blood Transfusion; Common Bile Duct; Drug Interactions; Epoprostenol; Hemorrhage; Hypertension, Portal; Indomethacin; Ligation; Lypressin; Male; Rats; Rats, Wistar; Splanchnic Circulation; Terlipressin; Vasoconstriction | 2001 |
Chronic inhibition of nitric oxide ameliorates splanchnic hyposensitivity to glypressin in a hemorrhage-transfused rat model of portal hypertension.
Topics: Animals; Antihypertensive Agents; Blood Transfusion; Drug Synergism; Enzyme Inhibitors; Hemodynamics; Hemorrhage; Hypertension, Portal; Lypressin; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Splanchnic Circulation; Terlipressin; Vasoconstrictor Agents | 2000 |
New method of cardiac output measurement using ultrasound velocity dilution in rats.
Topics: Animals; Antihypertensive Agents; Aorta; Blood Flow Velocity; Blood Pressure; Cardiac Output; Hypertension, Portal; Indicator Dilution Techniques; Losartan; Lypressin; Male; Microspheres; Observer Variation; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Terlipressin; Ultrasonography; Vasoconstrictor Agents | 2001 |
Comparative effects of the novel vasotocin analogue F-180 vs. vasopressin and terlipressin on systemic and splanchnic isolated vessels from portal hypertensive rats.
Topics: Animals; Hypertension, Portal; Lypressin; Male; Mesenteric Arteries; Mesenteric Veins; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Terlipressin; Vasoconstriction; Vasoconstrictor Agents; Vasopressins | 2001 |
Life, death, and varices.
Topics: Antibiotic Prophylaxis; Antihypertensive Agents; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Portasystemic Shunt, Transjugular Intrahepatic; Sclerotherapy; Terlipressin; Treatment Outcome | 2001 |
[The effect of terlipressin (Remestyp Spofa) on hemodynamic parameters in patients with portal hypertension associated with liver cirrhosis].
Topics: Hemodynamics; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Terlipressin | 1989 |
Hemodynamic changes of systemic, hepatic, and splenic circulation following triglycyl-lysin-vasopressin administration in alcoholic cirrhosis.
Topics: Adult; Aged; Blood Circulation; Female; Hemodynamics; Humans; Hypertension, Portal; Liver Circulation; Liver Cirrhosis, Alcoholic; Lypressin; Male; Middle Aged; Regional Blood Flow; Splanchnic Circulation; Spleen; Terlipressin | 1988 |
[Ischemia of the cecum caused by glycylpressin].
Topics: Cecum; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Ischemia; Lypressin; Male; Middle Aged; Necrosis; Stomach Ulcer; Terlipressin | 1985 |